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ABSTRACT 
Medical imaging plays an important role in diagnosis and treatment of multiple diseases. It is a 
field under continuous development which seeks for improved sensitivity and spatiotemporal 
resolution to allow the dynamic monitoring of diverse biological processes that occur at the micro- 
and nanoscale. Emerging technologies for targeted diagnosis and therapy such as nanotherapeutics, 
micro-implants, catheters and small medical tools also need to be precisely located and monitored 
while performing their function inside the human body. In this work, we show the real-time 
tracking of moving single micro-objects below centimeter thick tissue-mimicking phantoms, using 
multispectral optoacoustic tomography (MSOT). This technique combines the advantages of 
ultrasound imaging regarding depth and temporal resolution with the molecular specificity of 
optical methods. The resulting MSOT signal is further improved in terms of contrast and 
specificity by coating the micro-objects’ surface with gold nanorods, exhibiting a specific 
absorption peak at 820 nm wavelength facilitating their discrimination from those peaks of 
intrinsic tissue molecules when translated to in vivo settings. 
 
INTRODUCTION  
There is great interest in healthcare to perform deep tissue imaging with high spatiotemporal 
resolution for studying biological events like microcirculation, micro-angiogenesis, micro-
lymphangiogenesis, tumor metastasis, vascularization of implanted materials, cell migration or 
nanotherapeutic activity in order to gain more insights into the molecular dynamics of a disease 
progression/regression in a non-invasive manner.1–6 A further emerging field which is seeking for 
advanced imaging techniques is that of medical microrobotics. Tethered and untethered 
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microdevices which are being developed to perform non-invasive or minimally invasive diagnosis 
and therapy, microsurgery,7 and drug delivery8,9 are usually controlled and/or guided by physical 
means (e.g. magnetic field, ultrasound, etc.) and need precise localization and tracking to perform 
the intended functional tasks.10 So far, different imaging techniques have been explored but most 
of them bear insurmountable limitations. Briefly, fluorescent imaging (FI) has limited penetration 
depth due to significant light scattering in tissues.11 Ultrasound (US) offers millimeter to 
centimeter depth penetration with micrometer resolution,12 but it lacks providing molecular 
information. Computer tomography (CT) provides deep tissue penetration but utilizes ionizing 
radiation.13 MRI offers submillimeter resolution and in some cases temporal resolution in the 
milliseconds range but demands expensive infrastructure and continuous presence of strong 
magnetic fields.14 Another imaging modality, so-called PET/SPECT, which combines positron 
emission tomography (PET) and single photon emission computed tomography (SPECT), offers 
high sensitivity15 and molecular information, but utilizes radioactive energy. 
In the field of medical microrobots where real-time tracking inside deep tissue is required to bring 
this technology to the clinic,10 various attempts have been carried out so far. For example,  
microscopic bubbles from fast-moving microjets16 were visualized by using an ultrasound device. 
Servant et al. imaged a swimming swarm of around 10.000 artificial bacterial flagella in a living 
mouse by using fluorescence microscopy.17 Likewise, Felfoul et al. tracked a cluster of 
magnetotactic bacteria (5x107 bacteria per mL) by using magnetic resonance imaging.18 Positron 
emission tomography (PET) combined with X-ray computed tomography (CT) was also used to 
image swarms of catalytic micromotors. However, this technique required radioactive isotopes and 
the temporal resolution (7 frames in 15 min) was low.19 Recently, Yan et al. presented 
multifunctional bio-hybrid robots based on naturally occurring microalgae organisms, Spirulina 
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platensis that are biodegradable, traceable by infrared and magnetic resonance and cytotoxic to 
cancer cells.20 In that experiment a high concentration of material and contrast agents were needed 
and real-time tracking of individual or few moving micro-objects was not demonstrated.  
Within this context, optoacoustic imaging appears to be a promising technique as it allows real-
time imaging in deep tissue,21 a resolution in the µm range and molecular specificity which is 
required for distinguishing the spectral signatures of the micro-objects from surrounding tissue for 
future in vivo studies.22–26 Multispectral optoacoustic tomography (MSOT) relies on excitation of 
molecules by nanosecond pulsed near-infrared laser light and detection of emitted acoustic waves 
by highly sensitive ultrasound detectors. When laser pulses are absorbed by tissue, the tissue 
expands and contracts (thermoelastic expansion), giving off pressure waves that can be detected 
by ultrasound detectors and accordingly mapped as 2D cross-sectional or 3D volumetric images. 
These images have high contrast (dependent on the molar extinction coefficient of the absorbers) 
and high spatial resolution (dependent on the center frequency of the transducer). This approach 
has been demonstrated to reach a resolution of about 150 micrometers at depths of 2–3 
centimeters.27 MSOT has been used so far to image anatomical features like human 
vasculature,28,29 to assess fatty tumors,30 monitor blood flow and oxygen state,31 and to detect 
melanoma cells in sentinel lymphnodes32 – but not yet dynamically for tracking single moving 
micro-objects. 
Similar to other imaging modalities, contrast agents can be used to improve image contrast and 
targeting in MSOT. In particular nanoparticles or molecular chromophores with strong optical 
absorptivity and characteristic spectral profiles in the NIR spectral range are preferred. Among 
various contrast agents,33,34 gold nanorods (AuNRs) are excellent candidates due to their 
absorption spectrum which can be tuned across the NIR region by varying their size and shape, 
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35,36 and their molar extinction coefficients are much higher than those of endogenous tissue 
chromophores like water, melanin, and hemoglobin.37 AuNRs have been previously used for cell 
tracking.38 First, AuNRs were uptaken by cells via endocytosis for further optoacoustic tracking, 
however, after cell uptake, the confinement and the presence of endosomes lead to the AuNRs 
plasmon band broaden and reduced absorbance. Therefore, the authors of this work showed that 
by coating the AuNRs with silica, they can provide them with steric hindrance which improve the 
resulting photoacoustic signal and preserved their spectral properties. This approach allowed the 
tracking of 2x104 mesenchymal stem cells in mice over a period of 15 days with high spatial 
resolution and without affecting the viability or differentiation potential of the transplanted cells.38 
Optoacoustic imaging has also been used to screen ovarian cancer cells for early diagnosis. In this 
work, AuNRs were used as passively targeted molecular imaging agents, showing the highest 
photo-acoustic (PA) signal ex vivo and in vivo (in mice) for an aspect ratio of 3.5. After 3h, the 
maximum PA signal was observed for the 2008, HEY, and SKOV3 ovarian cancer cell lines in 
living mice, and a linear relationship between the PA and the concentration of injected molecular 
imaging agent was observed with limits of detection of 0.4 nM AuNRs, being lower than other 
labels in the literature.39  
In this work we present for the first time the real-time and high-precision tracking of individual 
micro-objects in three dimensions in tissue-mimicking phantoms down to ca. 1 cm depth. These 
results provide an excellent initial opportunity to demonstrate the feasibility of using MSOT to 
track single micro-objects in deep tissue, complying to well-accepted ethical rules according to the 
“3R” principles (“Replace, Reduce, Refine”).40 This means that we employ phantom tissues to 
avoid the early waste of living species in a research field that is still in its very infancy when 
considering to translate medical microrobotics into clinical practice.  
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RESULTS AND DISCUSSION 
MSOT principle and setup 
A cylindrical tissue-mimicking phantom with a diameter of 2 cm was placed in a holder and 
submerged in a water tank in a horizontal position to ensure acoustic coupling (Figure 1A). The 
laser beam and detector transducer array were in a fixed position during the entire data acquisition. 
The phantom was illuminated by short pulses of laser light in the near-infrared which was absorbed 
by the molecules inside the phantom and the embedded micro-objects. The magnitude of absorbed 
light was proportional to the optical absorption properties of the imaging target and local light 
intensity.26 The pressure signals, resulting from thermoelastic expansion, were simultaneously 
collected by 256 detector elements positioned in a tomographic way and further processed to 
obtain cross-sectional images of the phantom in which the micro-objects were located (Figure 
1B). Optoacoustic signal intensities in the images correlate directly to the absorption properties of 
the micro-objects at the illuminated wavelengths. Images shown in this study were reconstructed 
using filtered back-projection algorithms.41 
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Figure 1. Schematic of the experimental setup using multispectral optoacoustic tomography: 
(A) MSOT imaging system, illustrating the position of the phantom, the micro-objects, the 
excitation source and the ultrasound detectors, (B) Principle of MSOT operation. The phantom is 
illuminated by light pulses, which then results in local heat (absorption of light) that induce 
pressure waves due to contraction and expansion of the molecules. These waves are captured by 
ultrasound detectors and sampled simultaneously using analog to digital converters. Finally, the 
resulting signal is converted into an optoacoustic image by using post-processing algorithms. 
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Micro-objects fabrication and labeling  
3D printed conical micro-objects as model structures (diameter large opening = 12 µm, diameter 
small opening = 6 µm and different lengths: 25, 50 and 100 µm), were fabricated using two-photon 
lithography42 and coated with Cr/Ni/Ti by electron beam evaporation to allow their magnetic 
propulsion and guidance (Figure 2A). Afterwards, the structures were covered with Al2O3 by 
atomic layer deposition (ALD) to improve their biocompatibility and to facilitate the surface 
functionalization with AuNRs. Commercially available AuNRs with an absorption peak around 
820 nm and a size of 10 nm in width and 41 nm in length were covered with a dense layer of 
hydrophilic polymers that shield the gold surface and provide long circulation times for in vivo 
applications. The polymers also contained carboxyl groups that could be used as anchoring points 
for immobilization on the micro-objects. To achieve this immobilization, the Al2O3 layer of the 
micro-objects was first activated with oxygen plasma to increase the amount of hydroxyl groups 
on the surface, then immersed in (3-Aminopropyl)triethoxysilane (APTES), which binds to the 
hydroxyl groups through the silicon atoms of the APTES, leaving exposed amino groups. The 
carboxylic groups of the AuNRs were attached to these amino groups via carbodiimide chemistry.   
The density of the attached AuNRs was optimized by functionalizing the micro-objects with three 
different AuNRs concentrations (75, 150 and 300 µg/mL), which resulted in three final densities 
(40, 64 and 96 AuNRs/µm2), after washing. SEM images in Figure 2B show the distribution of 
gold nanorods onto the micro-object surface per each case. The ratio between the MSOT signal 
from functionalized micro-objects (with different AuNRs concentrations) and the non-
functionalized micro-objects, both previously coated with Cr/Ni/Ti/Al2O3, was obtained in the 
range of 680-980 nm. A well-defined absorption peak at 820 nm was observed for the different 
AuNRs densities. Such signal was obtained considering the average of at least three different 
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measured objects (Figure 2C). The measured peak was also in good agreement with the spectrum 
obtained by optical spectroscopy when the initial AuNRs suspension (before functionalization) 
was measured (Figure S1). 
The employed functionalization protocol is very well-stablished in the literature and has been used 
to attach diverse carboxylate particles or molecules such as fluorophores, enzymes, or antibodies, 
onto amino-modified surfaces, with good stability in physiological environments.43 The 
nanostructures have been used in more complex models in vivo (mouse model) and in vitro (human 
cells),39,43 preserving their stability over long periods of time and not showing cell toxicity or loses 
on the PA signal.  
 
Figure 2. Characterization of micro-objects: (A) SEM images of an array of 3D printed micro-
objects before AuNRs functionalization. (B) Spectral absorbance of the AuNRs-coated micro-
objects embedded in agarose phantom for three different densities of AuNRs in relation to the non-
functionalized micro-objects. The graph displays the ratio of MSOT signals obtained for AuNR-
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coated micro-objects and micro-objects without AuNRs. Insets show the corresponding MSOT 
signals for micro-objects with three different AuNR densities. The signal corresponds to the 
average of three measured spots (as the ones displayed in the left side, images taken at 820 nm 
wavelength excitation) and the error bars correspond to the standard deviation between the 
different measurements. (C) High magnification SEM images of the micro-objects before and after 
functionalization with AuNRs (0, 40, 64 and 96 AuNRs/µm2).  
 
Micro-objects embedded within phantoms and their corresponding MSOT signal 
Two different kinds of phantoms were fabricated, polydimethylsiloxane (PDMS)-glycerol and 
agarose containing soya milk, to systematically localize the micro-objects of different sizes in 
these two types of phantoms. The mixture of PDMS-glycerol is an emulsion formed of glycerol-
filled micron-sized cavities suspended in a PDMS matrix. These phantoms are robust and easy to 
handle compared to agarose or gelatin-based phantoms and mimic lung and bone tissues due to 
their morphological similarity.44 The absorbance of the PDMS-glycerol and agarose phantoms 
with a thickness of 10 mm was measured using vis-NIR spectroscopy (Figure S2). As the speed 
of sound in agarose is matched to that of the surrounding water bath, single micro-objects were 
visualized with high precision compared to those embedded in PDMS-glycerol phantoms which 
have a mismatch of 150 m/s compared to water. Agarose phantoms are also cheap, easy to produce, 
non-toxic, disposable and durable at high temperatures, and their properties can be easily tuned by 
adding different amounts of soya milk to obtain scattering coefficients similar to those of regular 
tissues.45 The agarose phantom was formed in a syringe of 2 cm in diameter and 5 cm in length. A 
first layer of liquid agarose was poured into the syringe and solidified for 30 minutes inside a 
fridge.  Then a drop of 10 µL of water containing the micro-objects was placed on top for drying. 
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Finally, a second layer of agarose was poured onto the micro-objects to complete the embedding 
procedure (Figure 3A).  
In a first set of experiments, the micro-objects with a length of 100 µm were embedded within the 
phantoms and then visualized in single cross sections of the phantoms at a single wavelength of 
820 nm (AuNRs absorption peak). All images were frequency-filtered from 1.8 MHz to 7 MHz in 
order to exclude the low frequency distribution from the phantom material. Each bright spot 
indicates the position of a single micro-object functionalized with a certain density of AuNRs (0, 
40, 64 and 96 AuNRs/µm2) (Figure 3B, i-iv). It was possible to locate individual micro-objects 
and visualize their distribution inside the phantoms. For this purpose, we took optical images of 
the same phantoms with micro-objects during the fabrication process before pouring the second 
layer of agarose. Bright-field images correlate well with the MSOT data and reveal matching 
locations of the micro-objects before and after imaging analysis (red rectangle, Figure 3B, 3C and 
S3). We observed that the optoacoustic signal from static micro-objects was proportional to the 
areal concentration of AuNRs (Figure 3D). Moreover, we measured the spot size, corresponding 
to a single micro-object, in the MSOT image finding out that it was ~5 times larger than the real 
length of the micro-object (100 µm) due to resolution limits imposed by the used detector array.  
It is also worth noting that the non-functionalized micro-objects also absorb light. This is due to 
the fact that the micro-objects were coated with different metal layers (Cr, Ni and Ti) before 
functionalization to provide them with magnetic properties and a biocompatible coating. Such 
materials also possesses plasmon resonance, but the intensity of the signal and its spectrum differs 
from the objects functionalized with gold nanorods as it can be observed in Figure 2B and S4.  
To evaluate the accuracy of the single micro-object position, we measured the distance between 
micro-objects in both MSOT and bright-field images. We chose different regions of interest (ROI) 
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where two adjacent micro-objects were located and measured the distance between them using 
imageJ. First, we determined the maximum pixel intensity, which corresponds to the highest part 
of the micro-object (large opening of the lying conical microstructure) and measured the distance 
between those points. The same procedure was carried out with the bright field image as shown in 
Figure 3C. The distance in MSOT (ROI1) and bright-field (ROI2) images was measured to be 
770 µm and 830 µm, respectively, with a distance difference of 60 µm. The average distance 
difference between the micro-objects in MSOT and BF was about 108 µm, after analyzing 4 
different cases (Figure 3C and S5). This position shift could arise due to slight displacements of 
micro-objects after pouring the second layer of agarose phantom.  
This study was extended to smaller micro-objects (25 and 50 µm in length) and repeated under the 
same experimental conditions with different concentrations of AuNRs (Figure S6). The obtained 
MSOT signal depends on the concentration of AuNRs on the micro-object’ surface as well as on 
the micro-objects size as long as it is within the spatial resolution of the used system, which is the 
current case (see Figure S6). Smaller micro-objects generate less signal as compared to the bigger 
micro-objects and this is due to small area covered by the same density of AuNRs. Finally, in order 
to confirm that MSOT is suitable to visualize other type of microstructures, we prepared agar 
phantoms containing a swarm of helical and cylindrical microstructures below 50 µm size (coated 
with Cr, Ni and Ti) and a similar MSOT signals were obtained as shown in Figure S7.   
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Figure 3. MSOT signal of static micro-objects embedded within tissue mimicking phantom: 
(A) Schematic representation of phantom preparation. Micro-objects were embedded within the 
phantom for static imaging studies, (B) MSOT signal of fully embedded micro-objects with 
different densities of AuNRs i) 0, ii) 40, iii) 64 and iv) 96 AuNRs/µm2, and their corresponding 
bright-field images prior to the embedding procedure. (C) Comparison of the measured distance 
between two micro-objects derived from MSOT (770 µm) and bright field (830 µm) images, 
resulting in a distance difference of 60 µm, and (D) MSOT signals from micro-objects (100 µm in 
length) embedded within agarose phantoms (~ 1 cm depth) and with different density of AuNRs. 
MSOT tracking of micro-objects 
In the second set of experiments, a semi-cylindrical agarose phantom with an internal channel 
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cavity of 3 mm in diameter was prepared and placed onto a hand-held imaging detector.  Acoustic 
gel was applied between the detector surface and the phantom for acoustic coupling (Figure 4A). 
The channel was treated with surfactant (1% w/v, SDS) to reduce the attachment of the micro-
objects to the inner wall surface.  Afterwards, AuNRs-coated micro-objects were injected into the 
channel which was later sealed to avoid undesired flows during the micro-objects’ actuation. The 
micro-objects were moved forward by an external magnetic field (~ 60 mT). The magnetic field 
gradient was measured using the positioning of a magnet with respect to a Hall sensor over a 
distance of 0 to 3 cm (Figure S8). As the measurement was performed with a hand-held detector 
image blurring was avoided by using single pulse acquisition at a single wavelength (820 nm) with 
a temporal resolution of 10 frames per second (fps). Ultrasound signals were collected by 256 
detector elements with an angular coverage of 270°. The data was processed by a workstation 
deconvoluting the signal from the electrical impulse response of the detectors. Band-pass filtering 
with cut-off frequencies between 1.8 and 7 MHz (maximum frequency available for the hand-held 
detector) was applied in order to exclude the low frequency signal distribution from the phantom.  
The information from MSOT images was extracted by employing image reconstruction algorithms 
based on the back-projection approach described elsewhere.46 The optoacoustic imaging 
parameters including frequency and wavelength ranges, acquisition time, and recording speed are 
given in Table 1. 
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Figure 4. Real-time tracking of single micro-object covered by 96 AuNRs/µm2: (A) Schematic 
showing the 3D hand-held detector for real time tracking of the micro-objects inside a channel 
cavity located approximately 8 mm deep within a tissue-mimicking phantom plus ca. 2 mm 
corresponding to the gel placed in between the phantom and the detector to improve the acoustic 
coupling, resulting in approximately 1 cm depth, (B) Time-lapse images of a 100 µm micro-object 
moving over a time period of 2.7 s (travel distance = 3.1 mm). Yellow arrows point at static micro-
structures which were stuck on the phantom surface and which are used here as reference points. 
Red lines mark the trajectory of a single moving micro-object after different time intervals, (C) 
Optical microscopy tracking of a single micro-object over the same period of time (2.7 s) in an 
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open agarose channel to compare the velocity and traveled distance (2.9 mm) within the same time 
interval. 
Table 1: Optoacoustic imaging parameters for visualization of micro-objects in phantoms 
MSOT imaging parameters (static) 
 
Wavelength (nm) 680-980 nm Detector (static) 256 elements 
Frequency (MHz) 5 MHz High energy 100 mJ 
Penetration depth 2-4 cm possible Spatial resolution 150 µm 
Acquisition time < 100 ms (single wavelength) , < 1s (multispectral) 
MSOT tracking parameters (dynamic) 
 
Wavelength (nm) 820 nm Detector (dynamic) 256 elements 
Frequency (MHz) 8 MHz Spatial resolution 80 µm 
Penetration depth 1.5 cm Frame rate (live) 10 fps 
 
Figure 4 summarizes the results from the dynamic imaging of the micro-objects demonstrating 
the performance ability of MSOT. The trajectory of a single micro-object is depicted in the time-
lapse images extracted from video S1. The single micro-object (100 µm long) took 2.7 s to travel 
3.1 mm (Figure 4B). The speed of the AuNR-coated micro-objects based on the measured 
trajectories from the MSOT video was 1160 µm/s. To validate these experiments, bright-field 
videos were recorded in a similar fashion by preparing the same kind of phantom channel, except 
that the channel was left open on the top side for optical tracking (Figure 4C). The measured speed 
of the single micro-objects over 2.7 s and a travel distance of 2.9 mm was 1070 µm/s, agreeing 
with the results obtained from the MSOT tracking experiment. The dynamic tracking performance 
of a single micro-object is visualized in Video S1 comparing MSOT and bright-field tracking. The 
hand-held detector also allowed us to capture real-time volumetric three-dimensional images at a 
rate of 10 fps (Video S2). The average length of a moving micro-object at different locations along 
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the trajectory was ~ 585±40 µm. To validate this, the average length of static micro-objects 
(imaged with different end-detector) was approximately 525±50 µm confirming similar sensitivity 
and spatial resolution for both detector arrays.  
 
CONCLUSIONS 
We demonstrated that MSOT can be used to track single moving micro-objects (100 µm in length) 
in real-time in a tissue-mimicking phantom with a penetration depth of ~ 1 cm. Such micro-objects 
can be later used as drug carriers or as components of medical microrobots to perform a medical 
task in living organisms. We established the localization of individual micro-objects with a 
precision of ca. 100 µm, within phantom tissues which mimic the absorption/scattering properties 
of real biological tissues, as previously reported in the literature.52  
The average length of a single micro-object under static and dynamic MSOT was determined to 
be 525 ± 50 µm and 585 ± 40 µm, respectively, being approximately 5 times larger than the real 
micro-object length (100 µm).  Moreover, we could enhance the contrast and selectivity of the 
MSOT signal by coating the micro-objects with AuNRs as they exhibit a strong absorption peak 
at 820 nm wavelength, which differs from chromophores that are present in living tissues like 
melanin, oxyhemoglobin, water, among others, which have relatively broad absorption peaks and 
low absorbance.53 
We obtained excellent agreement between the MSOT measurements and the optical analysis in 
both static and dynamic experiments. The ability of 3D tracking shows great potential to operate 
and monitor microstructures in living organisms as medical microrobots, micro-implants, 
microcatheters or diagnoses tools for further in vivo applications. In summary, MSOT emerges as 
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a promising new tool for localization and tracking of single moving micro-objects in hard-to-reach 
target sites, which could significantly improve the accuracy and effectiveness of current diagnosis 
and therapeutics in near future.  
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